<?xml version="1.0" encoding="UTF-8"?>
<ref id="B8">
 <label>8</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lyu</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Kong</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Mu</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Y</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Hepatic Arterial Infusion of Oxaliplatin Plus Fluorouracil/Leucovorin vs. Sorafenib for Advanced Hepatocellular Carcinoma</article-title>. 
  <source>J Hepatol</source> (
  <year>2018</year>) 
  <volume>69</volume>:
  <page-range>60–9</page-range>.  
  <pub-id pub-id-type="doi">10.1016/j.jhep.2018.02.008</pub-id>
 </mixed-citation>
</ref>
